If you're a human and see this, please ignore it. If you're a scraper, please click the link below :-)
Note that clicking the link below will block access to this site for 24 hours.
A Pennsylvania House resolution urges all businesses to increase the number of women on their boards by the end of the New Year, but a new report suggests this goal may be out of reach.
The Northeast Philadelphia cancer center will offer Abecma — a CAR T-cell therapy targeting myeloma cells — to patients who have previously tried at least four different treatments.
Secrets From the C-Suite, presented by Bank of America, talked to business leaders throughout the city about the challenges of the past year, and the promise of the year to come. Watch the discussions here.
The new collaboration between CHOP, the Netter Center, and Uplift seeks to help children in West and Southwest Philly and their families cope with trauma from community violence and the pandemic.
The Fox Chase Cancer Center senior director of community outreach recently co-authored a paper on ways to decrease cancer care disparities in medically underserved communities in America.
From a team that wants to be your new internet provider to another that's tackling mental illness with tech, these promising young companies are working on big solutions.
Directed by critical care doctor Renyu Liu, Wake Up Stroke 120 won Best Short Narrative Film and the Humanitarian Award at this year’s New York City International Film Festival.
Scientists from Temple’s Lewis Katz School of Medicine and local biopharma company Neuropathix are testing their compound, KLS-13019, which is intended to target chemotherapy-induced pain in cancer patients.
From why Philly is a great place to start a life sciences company to the ways the industry can be more inclusive, here’s what the experts had to say during this year’s virtual Philly Tech Week.
From a team that wants to be your new internet provider to another that's tackling mental illness with tech, these promising young companies are working on big solutions.
WindMIL Therapeutics is targeting marrow-infiltrating lymphocytes (MILs) to create a treatment to destroy cancer cells in patients, no matter their tumor type.
After decades of struggle, we’re finally seeing real-world, life-changing applications right here in Philadelphia. Has medicine finally got gene therapy right?